Meetings - The ASCO Post

This is Part 3 of ALK-Positive Metastatic NSCLC: Where Are We Now?, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Todd Bauer, ...

lung cancer

/ ALK-Positive Metastatic NSCLC: Where Are We Now

First-Line ALK-Positive NSCLC With CNS Metastases at Baseline and CNS Toxicity

This is Part 2 of ALK-Positive Metastatic NSCLC: Where Are We Now?, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Todd Bauer, ...

lung cancer

/ ALK-Positive Metastatic NSCLC: Where Are We Now

First-Line ALK-Positive NSCLC With CNS Metastases at Baseline

This is Part 1 of ALK-Positive Metastatic NSCLC: Where Are We Now?, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Todd Bauer, ...

ALK-Positive Metastatic NSCLC: Where Are We Now

Second-Line ALK-Positive NSCLC With CNS Progression on First-Line Crizotinib

First-Line ALK-Positive NSCLC With CNS Metastases at Baseline and CNS Toxicity

First-Line ALK-Positive NSCLC With CNS Metastases at Baseline

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma